C3 glomerulopathy

C3 glomerulopathy often starts when a part of the immune system called complement stays overactive. This can happen because of autoantibodies that keep complement switched on, or changes in genes that help control it. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t). Infections, autoimmune conditions, and abnormal proteins from the bone marrow can trigger or worsen C3 glomerulopathy. Clear lifestyle risk factors for C3 glomerulopathy are limited, but treating infections promptly and managing blood pressure may reduce kidney strain.

Genetic risk factors

For many, C3 glomerulopathy links to inherited problems in the body’s complement system, a set of proteins that regulate immune activity. Carrying a genetic change doesn’t guarantee the condition will appear. Researchers have identified several genetic risk factors for C3 glomerulopathy, most involving rare variants or extra or missing copies of genes that control the alternative complement pathway. These changes can tip the balance toward overactivation of complement, leading to C3 buildup in the kidney filters.

• CFH variants: Changes in the CFH gene can weaken the main brake on the alternative complement pathway. This makes it easier for C3 fragments to collect in kidney filters and drive C3 glomerulopathy. Families may show different ages of onset and severity.

• C3 variants: Rare changes in the C3 gene can make its activity harder to switch off. The overactive protein feeds a loop of complement activation that favors C3 deposits in the glomeruli. In some families this risk is seen across multiple generations.

• CFB variants: Changes in the factor B gene can stabilize the complement activation loop. This can fuel ongoing C3 activation and glomerular deposits seen in C3 glomerulopathy. Reported families suggest a hereditary risk even when symptoms differ among relatives.

• CFI variants: Loss-of-function changes in the factor I gene reduce the body’s ability to switch off complement once it starts. Too little factor I activity allows C3 fragments to build up in the kidneys. Effects can range from mild to severe between family members.

• CFHR rearrangements: Extra, missing, or fused copies of CFHR genes can interfere with factor H’s protective role on kidney surfaces. These structural changes can tilt complement control toward overactivation and C3 deposition. Genetic testing can detect CFHR hybrid genes linked to C3 glomerulopathy.

• CFHR5 nephropathy: A duplicated segment within the CFHR5 gene, described most often in people of Greek Cypriot ancestry, predisposes to C3 glomerulopathy. It is inherited in many families across generations, though not everyone who carries it becomes ill. Kidney biopsy typically shows C3-dominant deposits.

• Common CFH/CFHR variants: Some common genetic patterns near CFH and CFHR genes subtly shift how complement is controlled. These patterns can raise susceptibility to C3 glomerulopathy but rarely cause disease on their own. They are considered risk modifiers rather than sole causes.

• Variable penetrance: The same genetic change can lead to different outcomes among relatives. Some carriers develop C3 glomerulopathy early, others later, and some never do. This variability likely reflects differences in other genes and natural fluctuations in complement activity.

Transmission

C3 glomerulopathy is not infectious. It cannot be “caught” from someone else through everyday contact, the air, food or water, or sex.

In some families, changes in genes that control the complement system (a part of the immune system) can raise the chance of developing C3 glomerulopathy; these changes may be passed down, sometimes from one parent and sometimes only when both parents carry a change, and they can also appear for the first time in a child. Many cases are not inherited at all and are linked to immune proteins (autoantibodies) that alter complement activity; these are not passed from parent to child. If C3 glomerulopathy runs in your family, a genetics professional can explain how C3 glomerulopathy is inherited and discuss testing for relatives.

When to test your genes

Consider genetic testing if you were diagnosed with C3 glomerulopathy at a young age, have a family history of similar kidney disease, or show low C3 levels without a clear cause. Testing can confirm complement pathway defects, guide targeted treatments, and inform monitoring for relatives. Ask your kidney specialist or genetic counselor about timing and test options.

Looking ahead can feel daunting, but most people with C3 glomerulopathy do best when care starts early and stays consistent. This condition tends to progress slowly for many, though the pace can vary a lot from person to person. Some people will have long stretches with stable kidney function and only mild swelling or fatigue, while others see a steady drop in filtration over years. Doctors call this the prognosis—a medical word for likely outcomes.

Over time, most people with C3 glomerulopathy develop chronic kidney disease, and about one-third may reach kidney failure within 10 years if the disease is active and untreated. The risk is higher when protein in the urine is heavy, blood pressure runs high, or kidney function is already reduced at diagnosis. Children and teens can be affected too, but their long-term course is also quite variable, and some respond well to targeted therapy. Mortality is mainly tied to complications of kidney failure and cardiovascular disease rather than the condition itself, especially in regions with access to dialysis and transplant.

Treatment can change the long-term path. Controlling blood pressure, reducing protein in the urine, and addressing the overactive complement pathway can slow or stabilize damage. After transplant, C3 glomerulopathy can come back in the new kidney, but careful monitoring and evolving therapies are improving outcomes. Talk with your doctor about what your personal outlook might look like, including early symptoms of C3 glomerulopathy that should prompt a check-in, such as new swelling, foamy urine, or rising blood pressure.

Treatment for C3 glomerulopathy focuses on protecting kidney function, controlling the immune-driven inflammation, and reducing protein and blood in the urine. Doctors often start with measures that also help heart and kidney health, such as blood pressure control (commonly with ACE inhibitors or ARBs), salt restriction, cholesterol management, and careful use of diuretics if there is swelling. Depending on disease activity, your nephrologist may add immune-targeted therapies, which can include corticosteroids, other immunosuppressive medicines, or complement pathway inhibitors used in specialized centers; a doctor may adjust your dose to balance benefits and side effects. If kidney function declines despite treatment, options can include dialysis and, in selected cases, kidney transplant, though the disease can recur and may call for complement-directed therapy around the time of transplant. Keep track of how you feel, and share this with your care team, since early symptoms of C3 glomerulopathy can be subtle and treatment plans often change over time.

In some people, C3 glomerulopathy stems from inherited changes in the complement system—a part of immunity that can become overactive and injure the kidneys. Having a gene change doesn’t always mean you will develop the condition. Variants in complement factor H or factor I, factor B, C3, or the CFHR gene family can raise risk, and certain CFHR gene rearrangements (hybrid genes or extra/lost copies) are a known cause in some families. Others develop C3 glomerulopathy without any family history because an acquired immune factor, such as C3 nephritic factor, or a new gene change unsettles the system. When it does run in families, the inheritance pattern may be dominant or recessive, and the age of onset and severity can differ widely from one relative to another. If a hereditary form is suspected, genetic testing for C3 glomerulopathy typically focuses on complement genes and can help estimate risks for relatives and guide monitoring, but results point to likelihood rather than a simple yes-or-no answer.

Someone might notice swelling and foamy urine worsen right after a bad cold or skin infection, then settle a bit once the infection clears. To understand overall health, it’s useful to see how conditions overlap. Infections can “switch on” the complement system and make C3 glomerulopathy flare, so episodes of strep throat, staph skin infections, or chronic infections like hepatitis B or C may coincide with rising protein in the urine or a drop in kidney function. In adults, C3 glomerulopathy sometimes occurs alongside a monoclonal gammopathy (an abnormal protein made by a small clone of plasma cells); treating that clone can reduce complement activation and help protect the kidneys. Many living with C3 glomerulopathy also develop high blood pressure and chronic kidney disease, which raise heart risks and can limit medication choices—nonsteroidal anti‑inflammatory drugs, for example, may worsen kidney function and are often avoided. Rarely, related conditions such as partial lipodystrophy or early-onset eye changes from drusen share the same complement pathway problem; when present, they can hint at early symptoms of C3 glomerulopathy and help guide testing and follow-up.

How genes can cause diseases

Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.

Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.